Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the Yersinia pestis Plague rF1V Vaccine

Relatively recent advances in plague vaccinology have produced the recombinant fusion protein F1-V plague vaccine. This vaccine has been shown to readily protect mice from both bubonic and pneumonic plague. The protection afforded by this vaccine is solely based upon the immune response elicited by...

Descripción completa

Detalles Bibliográficos
Autores principales: Biryukov, Sergei, Dankmeyer, Jennifer L., Shamsuddin, Zain, Velez, Ivan, Rill, Nathaniel O., Rosario-Acevedo, Raysa, Klimko, Christopher P., Shoe, Jennifer L., Hunter, Melissa, Ward, Michael D., Cazares, Lisa H., Fetterer, David P., Bozue, Joel A., Worsham, Patricia L., Cote, Christopher K., Amemiya, Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430260/
https://www.ncbi.nlm.nih.gov/pubmed/34512658
http://dx.doi.org/10.3389/fimmu.2021.726416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430260/
https://www.ncbi.nlm.nih.gov/pubmed/34512658
http://dx.doi.org/10.3389/fimmu.2021.726416

Ejemplares similares